Please assess the completion status of the following clinical trial:

Trial Title: Rectal Acetaminophen Use During Oocyte Retrievals to Reduce Post-Operative Opioid Utilization

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Any female patient undergoing oocyte retrieval by transvaginal ultrasound-guided ovarian puncture~Exclusion Criteria:~* Patients with chronic pain conditions such as fibromyalgia and sickle cell anemia.~* Patient with BMI greater than 40~* Patients that required general endotracheal intubation anesthesia in prior oocyte retrieval~* Patients with documented allergic reaction to acetaminophen~* Patient with contra-indication to the use of acetaminophen (liver disease)~* Patients with a history of past or current alcohol, drug or opioid abuse~* Patients with ulcerative colitis, Crohn's disease, or severe rectal hemorrhoids

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 56 Years
- Healthy Volunteers: t

Study Arms:
- Fentanyl/propofol + acetaminophen (Type: EXPERIMENTAL): In addition to the weight-based intraoperative IV dose of propofol and fentanyl per standard TGH Anesthesiology protocol, one dose of 1300 mg of solid base rectal acetaminophen suppository (2 suppositories) will be administered at the end of oocyte retrieval.
- Fentanyl/propofol only (Type: ACTIVE_COMPARATOR): Participants in this arm will receive the weight-based intraoperative IV dose of propofol and fentanyl per standard TGH Anesthesiology protocol.

Based on this trial design, predict the completion outcome and termination type (if applicable).